Login / Signup
Use of angiotensin receptor blocker is associated with improved 1 year mortality in heart failure with mid-range ejection fraction.
Bin Wang
Lihua Zhang
Shuang Hu
Xueke Bai
Xi Li
Jing Li
Xin Zheng
Published in:
ESC heart failure (2021)
Among patients hospitalized for HFmrEF, the use of ARB was associated with lower 1 year mortality after discharge.
Keyphrases
</>
ejection fraction
heart failure
angiotensin converting enzyme
aortic stenosis
angiotensin ii
cardiovascular events
left ventricular
risk factors
atrial fibrillation
acute heart failure
cardiac resynchronization therapy
type diabetes
coronary artery disease
transcatheter aortic valve replacement